Tarpeyo and Bumetanide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tarpeyo (budesonide) and Bumetanide (bumetanide). Common drug interactions include anger among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Tarpeyo and Bumetanide. It is created by eHealthMe based on reports of 8 people who take the same drugs from the FDA, and is updated regularly.

What is Tarpeyo?

Tarpeyo has active ingredients of budesonide. eHealthMe is studying from 2,758 Tarpeyo users. Check the latest studies of Tarpeyo.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,530 Bumetanide users. Check the latest studies of Bumetanide.



On Nov, 22, 2025

8 people who take Tarpeyo and Bumetanide together, and have interactions are studied.

Tarpeyo and Bumetanide drug interactions.

What are the common drug interactions of Tarpeyo and Bumetanide, by gender? *:

female:

  1. Anger
  2. Anxiety
  3. Mood swings (an extreme or rapid change in mood)
  4. Oedema (fluid collection in tissue)
  5. Weight increased
  6. Fall
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Glomerular filtration rate decreased
  9. Headache (pain in head)
  10. Nausea (feeling of having an urge to vomit)

male:

  1. Abdominal distension
  2. Gastroenteritis salmonella (inflammation of stomach and intestine caused by salmonella bacteria)
  3. Asthenia (weakness)
  4. Cellulitis (infection under the skin)
  5. Diarrhoea
  6. Dyspnoea (difficult or laboured respiration)
  7. Flatulence (flatus expelled through the anus)
  8. Lethargy (tiredness)
  9. Muscle spasms (muscle contraction)
  10. Weight increased

What are the common drug interactions of Tarpeyo and Bumetanide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  2. Nausea (feeling of having an urge to vomit)
  3. Vomiting

30-39:

  1. Headache (pain in head)

40-49:

  1. Asthenia (weakness)
  2. Diarrhoea
  3. Lethargy (tiredness)

50-59:

  1. Dyspnoea (difficult or laboured respiration)
  2. Flatulence (flatus expelled through the anus)
  3. Muscle spasms (muscle contraction)
  4. Weight increased
  5. Abdominal distension
  6. Gastroenteritis salmonella (inflammation of stomach and intestine caused by salmonella bacteria)
  7. Cellulitis (infection under the skin)

60+:

  1. Anger
  2. Anxiety
  3. Mood swings (an extreme or rapid change in mood)
  4. Oedema (fluid collection in tissue)
  5. Weight increased
  6. Fall
  7. Glomerular filtration rate decreased

* Approximation only. Some reports may have incomplete information.

Do you take Tarpeyo and Bumetanide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tarpeyo and Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tarpeyo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tarpeyo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bumetanide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on budesonide and bumetanide (the active ingredients of Tarpeyo and Bumetanide, respectively), and Tarpeyo and Bumetanide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: